Coeliac disease

ImmunogenX Initiates Phase 2 Trial for its Lead Therapeutic and Diagnostic Candidates Latiglutenase and CypCel

Retrieved on: 
Thursday, March 14, 2019
Health, Biotechnology, Clinical trials, Fitness & Nutrition, Genetics, Hospitals, Pharmaceutical, Manufacturing, Steel, Research, Diabetes, FDA, Science, General Health, Managed care, Health, Medicine, Articles, Clinical research, Gluten challenge test, Gluten sensitivity, Gluten, Placebo, Gluten-free diet, Coeliac disease

The trial will test the safety and efficacy of the companys lead therapeutic candidate Latiglutenase for the protection of intestinal health and the reduction of symptoms in the presence of a 6 week gluten challenge treatment period.

Key Points: 
  • The trial will test the safety and efficacy of the companys lead therapeutic candidate Latiglutenase for the protection of intestinal health and the reduction of symptoms in the presence of a 6 week gluten challenge treatment period.
  • Urine samples will also be collected periodically to measure gluten content for the placebo vs. latiglutenase arms during the gluten challenge period.
  • These investigators have worked together on a previous trial that focused on the CypCel diagnostic for disease management.
  • This trial represents an exciting opportunity to test our therapeutic drug Latigutenase alongside our diagnostic disease management tool CypCel.

Asia-Pacific Gluten-Free Foods & Beverages Market, 2019 - Expected to Grow at a CAGR of 12.4% During 2018-2023 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 5, 2019
Retail, Food, Beverage, Medical specialties, Health, Branches of biology, Gluten sensitivity, Diets, Gluten, Nutrition, Coeliac disease, Wheat allergy, Gluten-free beer, Udi’s Healthy Foods

The "Asia-Pacific Gluten-free Foods & Beverages Market - Segmented by Type and Geography (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Asia-Pacific Gluten-free Foods & Beverages Market - Segmented by Type and Geography (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
  • The market for gluten-free foods & beverages in Asia-Pacific has undergone a radical change from specialty niche products to mainstream products.
  • A current trend towards gluten-free product consumption has given further impetus to the gluten-free foods & beverages segment.
  • The gluten-free foods & beverages market in Asia-Pacific is expected to witness a CAGR of 12.4% during the forecast period, owing to the sizeable population of celiac disease patients.

imaware Launches At-Home Celiac Disease Monitoring Test

Retrieved on: 
Monday, January 21, 2019
Medicine, Health, Gluten sensitivity, Autoimmune diseases, RTT, Coeliac disease, Pediatrics, Celiac, Screening, Autoimmunity, Carlo Catassi

The new monitoring test follows the company's recent launch of its Celiac Disease screening test to provide people with comprehensive end-to-end testing and disease management tools for the autoimmune disease.

Key Points: 
  • The new monitoring test follows the company's recent launch of its Celiac Disease screening test to provide people with comprehensive end-to-end testing and disease management tools for the autoimmune disease.
  • "Celiac disease remains a highly underdiagnosed autoimmune disease affecting millions, with an estimated 60 percent who are not yet diagnosed," said Jani Tuomi, co-founder of imaware.
  • Designed alongside world-renowned doctors, "imaware is a simple and precise at-home screening test for celiac disease that should significantly reduce the number of undiagnosed patients over time," said Dr. Guandalini, Medical Director of the University of Chicago Celiac Disease Center and advisor to imaware.
  • The imaware at-home test for celiac disease screening and monitoring are both available at imaware.health for $99 USD each.

SQI Diagnostics' Direct-to-Consumer Partner Launches At-Home Celiac Disease Awareness Test

Retrieved on: 
Monday, December 10, 2018
Autoimmune diseases, RTT, Medicine, Gluten sensitivity, Health, Gastrointestinal tract disorders, Celiac, Coeliac disease, Anatomy, Sjögren syndrome, Nexvax2

As of today, the imaware at-home test for celiac disease developed alongsideMicrodrop is available for purchase, with several other disease tests planned for the coming months.

Key Points: 
  • As of today, the imaware at-home test for celiac disease developed alongsideMicrodrop is available for purchase, with several other disease tests planned for the coming months.
  • "We are excited to play such an important role in Microdrop's imaware product launch," said Andrew Morris, CEO of SQI Diagnostics.
  • Run on SQI's automated systems, the imaware at-home test for celiac disease addresses a current unmet need in the market today.
  • imaware has also partnered with Beyond Celiac, a leading national celiac disease advocacy group, to help reduce the number of undiagnosed patients.

Amgen And Provention Bio Announce Co-Development Collaboration In Celiac Disease

Retrieved on: 
Monday, November 5, 2018
Medicine, Health, RTT, Amgen, Gluten sensitivity, Immunology, Coeliac disease, Gluten, Monoclonal antibody, Arthritis, Genmab, B-cell activating factor

AMG 714 is a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease (NRCD).

Key Points: 
  • AMG 714 is a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease (NRCD).
  • "Celiac disease impacts millions of people around the world and remains the only common autoimmune disease with no approved therapeutic treatment," said David M. Reese, M.D., executive vice president of Research and Development at Amgen.
  • "Our AMG 714 co-development collaboration with Amgen is a significant milestone in the growth and advancement of Provention.
  • AMG 714 was initially developed by Amgen in rheumatoid arthritis and later investigated for possible use in celiac disease.

Seq2Know Launches Celiac Disease Genetic Test

Retrieved on: 
Wednesday, October 3, 2018
Medicine, RTT, Clinical medicine, Autoimmune diseases, Health, Gluten sensitivity, Medical genetics, Coeliac disease, Malnutrition, Genetic testing, Celiac, Sjögren syndrome

MARSHFIELD, Wis., Oct. 3, 2018 /PRNewswire/ --Genetic testing company Seq2Know is now offering Celiac disease testing.

Key Points: 
  • MARSHFIELD, Wis., Oct. 3, 2018 /PRNewswire/ --Genetic testing company Seq2Know is now offering Celiac disease testing.
  • According to Beyond Celiac , a Celiac awareness and advocacy organization, although 3 million Americans are living with Celiac, roughly 83% remain undiagnosed or misdiagnosed.
  • This enables anyone 18 or older to order the Celiac genetic test, without a trip to the doctor.
  • Seq2Know, a service of PreventionGenetics, LLC, is a high-quality, certified DNA testing laboratory offering genetic sequencing services to help people determine their genetic risk for hereditary disorders.

Gluten-free Products Market Worth $6.47 Billion by 2023

Retrieved on: 
Thursday, September 13, 2018
Health, Medicine, Gluten sensitivity, Gluten, Nutrition, Coeliac disease, Wheat allergy, Food and drink

The European market is projected to grow at the highest CAGR from 2018 to 2023.

Key Points: 
  • The European market is projected to grow at the highest CAGR from 2018 to 2023.
  • Increasing incidences of celiac diseases and gluten sensitivities have led to high demand for gluten-free products in the region.
  • This report includes a study of marketing and development strategies, along with the product portfolios of leading companies.
  • MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Global $3.9 Bn Gluten Free Packaged Food Market to 2023 - Celiac Disease and Gluten Intolerance / Increase in Obesity and Diabetes / Public Consciousness About Food

Retrieved on: 
Friday, September 7, 2018
Health, Diets, Gluten sensitivity, Medicine, Food, Gluten-free diet, Gluten, Coeliac disease, Food and drink, Udi’s Healthy Foods, Carol Kicinski

The "Global Gluten free packaged food Market - by Product, Source, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Gluten free packaged food Market - by Product, Source, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
  • The global gluten free packaged food market size was 2.68 billion USD in 2017 which has forecasted to reach 3.96 billion USD at a CAGR of 6.74% during the period.
  • Gluten free packaged products are a new phenomenon which has arisen due to increase in the number of celiac disease patients, change in consumption pattern of the people and consumer shift to convenience product.
  • China is the largest player in Asia Pacific region for gluten free packaged products.

Global Gluten Free Food Market Key Company Analysis, Sales, Demand, Industry Size and Forecasts 2023

Retrieved on: 
Friday, August 31, 2018
Food and drink, Health, Gluten sensitivity, Medicine, Gluten, Nutrition, Pasta, Coeliac disease, Carol Kicinski, Udi’s Healthy Foods

Additionally, on the back of an absence of treatment of celiac disease, the patient is bound to follow gluten free diet (GFD) for lifetime which not only propels the market for the gluten free food but also providing opportunities for the large food conglomerates and various home grown companies to venture in the gluten free food market.

Key Points: 
  • Additionally, on the back of an absence of treatment of celiac disease, the patient is bound to follow gluten free diet (GFD) for lifetime which not only propels the market for the gluten free food but also providing opportunities for the large food conglomerates and various home grown companies to venture in the gluten free food market.
  • Additionally, rising health related awareness, increasing labor force leading to rise in the affordability of premium food products, amplifying urbanized population is backing the demand for gluten free food products across the globe.
  • Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the Gluten Free Food Market.
  • Global Market- By Value (Actual Period: 2013-2017, Forecast Period: 2018-2023)
    Gluten Free Food Market - Sizing, Growth, Forecast
    Analysis By Type of Food - Bakery and Confectionery, Cereal and Baby Food, Ready Meals, Pasta and Pizza, Others
    Analysis By Sales Channel (Conventional Channel, Hospitals and Drug Stores, Specialty Stores, Hotels & Restaurants)

Health Test Express to Donate 100% of May Profits From New At-Home Test to the Celiac Disease Foundation

Retrieved on: 
Friday, May 4, 2018
Gluten sensitivity, Medicine, Health, Clinical medicine, Non-celiac gluten sensitivity, Gluten-related disorders, Coeliac disease, Gluten, Celiac, Carlo Catassi, Gluten-free beer

CHICAGO, May 4, 2018 /PRNewswire/ -- Health Test Express, the leading platform connecting patients to diagnostic services, announced today that they are donating 100% of the profits from their new Celiac Disease and Gluten Intolerance Test offering to the Celiac Disease Foundation during the month of May, which is Celiac Disease Awareness Month.

Key Points: 
  • CHICAGO, May 4, 2018 /PRNewswire/ -- Health Test Express, the leading platform connecting patients to diagnostic services, announced today that they are donating 100% of the profits from their new Celiac Disease and Gluten Intolerance Test offering to the Celiac Disease Foundation during the month of May, which is Celiac Disease Awareness Month.
  • "Health Test Express is proud to support the Celiac Disease Foundation's effort to accelerate treatments and a cure for celiac disease through research, education and advocacy," said Kevin Weinstein, CEO of Analyte Health, the company that owns Health Test Express.
  • Health Test Express exclusively offers a new, simple at-home blood test that can help identify specific antibodies associated with gluten sensitivity and the possibility of celiac disease.
  • These antibodies help to determine whether celiac disease is possible, gluten sensitivity is possible, or if there is very low probability of gluten sensitivity or celiac disease.